{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "http://www.kirschfoundation.org/#organization",
      "name": "Kirsch Foundation",
      "url": "http://www.kirschfoundation.org/",
      "description": "Kirsch Foundation '; Changes at the Kirsch Foundation In early October 2007, the Kirsch Foundation announced a major change in direction for the organization. After extensive deliberation, the Foundation’s Board of Directors made a decision to invest a substantial portion of its assets into research associated with Waldenstrom’s Macroglobulinemia. The Board came to learn about this rare blood cancer through Founder Steve Kirsch’s diagnosis with the disease in August."
    },
    {
      "@type": "WebPage",
      "@id": "https://asg.websdocs.com/directory/business/kirsch-foundation#asg",
      "name": "Kirsch Foundation ASG Directory Profile",
      "url": "https://asg.websdocs.com/directory/business/kirsch-foundation",
      "isPartOf": {
        "@id": "http://www.kirschfoundation.org/#organization"
      },
      "description": "Static AI-readable public business profile published by the WebsDocs ASG Directory."
    }
  ]
}